- Home
- WHLR vs SLRX Comparison
WHLR vs SLRX Comparison
Compare WHLR & SLRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WHLR
- SLRX
- Stock Information
- Founded
- WHLR 2011
- SLRX N/A
- Country
- WHLR United States
- SLRX United States
- Employees
- WHLR N/A
- SLRX N/A
- Industry
- WHLR Real Estate Investment Trusts
- SLRX Biotechnology: Pharmaceutical Preparations
- Sector
- WHLR Real Estate
- SLRX Health Care
- Exchange
- WHLR Nasdaq
- SLRX Nasdaq
- Market Cap
- WHLR 1.5M
- SLRX 1.8M
- IPO Year
- WHLR 2012
- SLRX N/A
- Fundamental
- Price
- WHLR $4.59
- SLRX $0.72
- Analyst Decision
- WHLR
- SLRX
- Analyst Count
- WHLR 0
- SLRX 0
- Target Price
- WHLR N/A
- SLRX N/A
- AVG Volume (30 Days)
- WHLR 238.1K
- SLRX 23.3K
- Earning Date
- WHLR 08-05-2025
- SLRX 05-14-2025
- Dividend Yield
- WHLR N/A
- SLRX N/A
- EPS Growth
- WHLR N/A
- SLRX N/A
- EPS
- WHLR N/A
- SLRX N/A
- Revenue
- WHLR $102,793,000.00
- SLRX N/A
- Revenue This Year
- WHLR N/A
- SLRX N/A
- Revenue Next Year
- WHLR N/A
- SLRX N/A
- P/E Ratio
- WHLR N/A
- SLRX N/A
- Revenue Growth
- WHLR 0.86
- SLRX N/A
- 52 Week Low
- WHLR $3.92
- SLRX $0.45
- 52 Week High
- WHLR $25,116.00
- SLRX $7.20
- Technical
- Relative Strength Index (RSI)
- WHLR 30.47
- SLRX 41.78
- Support Level
- WHLR $4.17
- SLRX $0.68
- Resistance Level
- WHLR $7.87
- SLRX $0.80
- Average True Range (ATR)
- WHLR 1.09
- SLRX 0.04
- MACD
- WHLR 0.74
- SLRX -0.01
- Stochastic Oscillator
- WHLR 13.19
- SLRX 8.93
About WHLR Wheeler Real Estate Investment Trust Inc.
Wheeler Real Estate Investment Trust Inc is a self-managed commercial real estate investment company. It owns, leases, and operates income-producing retail properties with a primary focus on grocery-anchored centers. The company's properties include Alex City Marketplace in Alexander City, Alabama; Bryan Station in Lexington, Kentucky; Cardinal Plaza in Henderson, North Carolina; Clover Plaza in Clover, South Carolina; Winslow Plaza in Sicklerville, New Jersey and many more.
About SLRX Salarius Pharmaceuticals Inc.
Salarius Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on developing effective treatments for cancers with high, unmet medical needs. The company has focused on two classes of drugs that address gene dysregulation: targeted protein inhibitors and targeted protein degradation. Its Pipeline includes seclidemstat (SP-2577), a small molecular inhibitor, and SP-3164, a small molecular protein degrader.